0001104659-19-019036.txt : 20190401
0001104659-19-019036.hdr.sgml : 20190401
20190401180104
ACCESSION NUMBER: 0001104659-19-019036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190329
FILED AS OF DATE: 20190401
DATE AS OF CHANGE: 20190401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Holles Natalie C.
CENTRAL INDEX KEY: 0001580111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38586
FILM NUMBER: 19722129
MAIL ADDRESS:
STREET 1: C/O HYPERION THERAPEUTICS, INC.
STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rubius Therapeutics, Inc.
CENTRAL INDEX KEY: 0001709401
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042688109
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-679-9600
MAIL ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
a4.xml
4
X0306
4
2019-03-29
0
0001709401
Rubius Therapeutics, Inc.
RUBY
0001580111
Holles Natalie C.
C/O RUBIUS THERAPEUTICS, INC.
399 BINNEY STREET, SUITE 300
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (Right to Buy)
18.10
2019-03-29
4
A
0
50000
0
A
2029-03-28
Common Stock
50000
50000
D
This option shall vest in equal quarterly installments over the twelve quarters following the grant date.
/s/ Joanne M. Protano, Attorney-in-Fact
2019-04-01